<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; way</title>
	<atom:link href="http://www.tapanray.in/tag/way/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Keep Pace with Pharma’s Even Nuanced Technology Driven Changes &#8211; For Success</title>
		<link>http://www.tapanray.in/keep-pace-with-pharmas-even-nuanced-technology-driven-changes-for-success/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=keep-pace-with-pharmas-even-nuanced-technology-driven-changes-for-success</link>
		<comments>http://www.tapanray.in/keep-pace-with-pharmas-even-nuanced-technology-driven-changes-for-success/#comments</comments>
		<pubDate>Mon, 14 Nov 2022 00:06:51 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[blessings]]></category>
		<category><![CDATA[burden]]></category>
		<category><![CDATA[changes]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[driven]]></category>
		<category><![CDATA[empathy]]></category>
		<category><![CDATA[employee]]></category>
		<category><![CDATA[excellence]]></category>
		<category><![CDATA[flexibility]]></category>
		<category><![CDATA[forward]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[leadership]]></category>
		<category><![CDATA[nuanced]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Place]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[success]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[way]]></category>
		<category><![CDATA[work]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10725</guid>
		<description><![CDATA[Since 2020, unprecedented global disruptions affecting lives, livelihoods, and business, have impacted India in equal measure, if not more &#8211; across various areas, including the pharma industry. If there is one change that is creating a snowballing effect, is the &#8230; <a href="http://www.tapanray.in/keep-pace-with-pharmas-even-nuanced-technology-driven-changes-for-success/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/keep-pace-with-pharmas-even-nuanced-technology-driven-changes-for-success/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Creating ‘Shared Value’ in Pharma – The Way Forward</title>
		<link>http://www.tapanray.in/creating-shared-value-in-pharma-the-way-forward/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=creating-shared-value-in-pharma-the-way-forward</link>
		<comments>http://www.tapanray.in/creating-shared-value-in-pharma-the-way-forward/#comments</comments>
		<pubDate>Mon, 30 Jul 2018 00:00:37 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[Arogya]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[creation]]></category>
		<category><![CDATA[CSR]]></category>
		<category><![CDATA[Declining]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[forward]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[high]]></category>
		<category><![CDATA[image]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Parivar]]></category>
		<category><![CDATA[philanthropy]]></category>
		<category><![CDATA[prices]]></category>
		<category><![CDATA[Progress]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reputation]]></category>
		<category><![CDATA[shared]]></category>
		<category><![CDATA[social responsibility]]></category>
		<category><![CDATA[social. society]]></category>
		<category><![CDATA[sustainable]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[trust]]></category>
		<category><![CDATA[value]]></category>
		<category><![CDATA[way]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9079</guid>
		<description><![CDATA[Many Pharmaceutical companies, both global and local, are struggling with a plethora of critical challenges. With the industry reputation diving south successful navigation through this headwind has become an onerous task, more than ever before. Under this backdrop, the article, &#8230; <a href="http://www.tapanray.in/creating-shared-value-in-pharma-the-way-forward/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/creating-shared-value-in-pharma-the-way-forward/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Should India follow the US way to regulate all types of lobbying in the country?</title>
		<link>http://www.tapanray.in/should-india-follow-the-us-way-to-regulate-all-types-of-lobbying-in-the-country/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=should-india-follow-the-us-way-to-regulate-all-types-of-lobbying-in-the-country</link>
		<comments>http://www.tapanray.in/should-india-follow-the-us-way-to-regulate-all-types-of-lobbying-in-the-country/#comments</comments>
		<pubDate>Mon, 31 Oct 2011 00:00:55 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[follow]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[lobbying]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[radia]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[regulate]]></category>
		<category><![CDATA[scam]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[types]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[way]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=181</guid>
		<description><![CDATA[Currently, India is one of the fastest-growing economies of the world along with China. Even during the recent global financial meltdown process both India and China could register a very impressive average GDP growth of around 7% consistently during the &#8230; <a href="http://www.tapanray.in/should-india-follow-the-us-way-to-regulate-all-types-of-lobbying-in-the-country/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/should-india-follow-the-us-way-to-regulate-all-types-of-lobbying-in-the-country/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abbott – Piramal deal: the way future is expected to shape up</title>
		<link>http://www.tapanray.in/abbott-piramal-deal-the-way-future-is-expected-to-shape-up/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=abbott-piramal-deal-the-way-future-is-expected-to-shape-up</link>
		<comments>http://www.tapanray.in/abbott-piramal-deal-the-way-future-is-expected-to-shape-up/#comments</comments>
		<pubDate>Mon, 31 May 2010 01:30:00 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[abbott]]></category>
		<category><![CDATA[acquisition]]></category>
		<category><![CDATA[branded]]></category>
		<category><![CDATA[deal]]></category>
		<category><![CDATA[expected]]></category>
		<category><![CDATA[future]]></category>
		<category><![CDATA[generics]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[M&A]]></category>
		<category><![CDATA[merger]]></category>
		<category><![CDATA[monopoly]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Piramal]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Shape]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[Up]]></category>
		<category><![CDATA[valuation]]></category>
		<category><![CDATA[way]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=421</guid>
		<description><![CDATA[In my view, these are still very early days for such acquisitions of large domestic Indian pharmaceutical companies by the Global Pharma majors to gain momentum in the country. However, there is no doubt that in the near future, we &#8230; <a href="http://www.tapanray.in/abbott-piramal-deal-the-way-future-is-expected-to-shape-up/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/abbott-piramal-deal-the-way-future-is-expected-to-shape-up/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Innovative Public Private Partnership (PPP) in Healthcare Financing is the way forward to improve ‘Affordability’ and ‘Access’ to Healthcare’ in India</title>
		<link>http://www.tapanray.in/innovative-public-private-partnership-ppp-in-healthcare-financing-is-the-way-forward-to-improve-affordability-and-access-to-healthcare-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=innovative-public-private-partnership-ppp-in-healthcare-financing-is-the-way-forward-to-improve-affordability-and-access-to-healthcare-in-india</link>
		<comments>http://www.tapanray.in/innovative-public-private-partnership-ppp-in-healthcare-financing-is-the-way-forward-to-improve-affordability-and-access-to-healthcare-in-india/#comments</comments>
		<pubDate>Mon, 03 May 2010 01:30:50 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Financing]]></category>
		<category><![CDATA[forward]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[improve]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[innovative]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[Partnership]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPP]]></category>
		<category><![CDATA[private]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[way]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=433</guid>
		<description><![CDATA[Despite various measures taken by the Government of India (GoI), around 65% of the population do not have access to modern medicines in the country. Such medicines do not include treatment just for ‘Tropical Diseases’ like, Malaria, Tuberculosis, Filariasis or &#8230; <a href="http://www.tapanray.in/innovative-public-private-partnership-ppp-in-healthcare-financing-is-the-way-forward-to-improve-affordability-and-access-to-healthcare-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/innovative-public-private-partnership-ppp-in-healthcare-financing-is-the-way-forward-to-improve-affordability-and-access-to-healthcare-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The need for urgent healthcare reform in India: The way forward.</title>
		<link>http://www.tapanray.in/the-need-for-urgent-healthcare-reform-in-india-the-way-forward/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-need-for-urgent-healthcare-reform-in-india-the-way-forward</link>
		<comments>http://www.tapanray.in/the-need-for-urgent-healthcare-reform-in-india-the-way-forward/#comments</comments>
		<pubDate>Tue, 22 Sep 2009 07:22:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[beds]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[deliver]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[forward]]></category>
		<category><![CDATA[GDP]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[hospitals]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[nurses]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Reform]]></category>
		<category><![CDATA[spend]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[urgent]]></category>
		<category><![CDATA[way]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=774</guid>
		<description><![CDATA[If we look at the history of development of the developed countries of the world, we shall see that all of them had invested and even now are investing to improve the social framework of the country where education and &#8230; <a href="http://www.tapanray.in/the-need-for-urgent-healthcare-reform-in-india-the-way-forward/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-need-for-urgent-healthcare-reform-in-india-the-way-forward/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Increasing penetration of Health Insurance: an important way to improve affordability and access to healthcare</title>
		<link>http://www.tapanray.in/increasing-penetration-of-health-insurance-an-important-way-to-improve-affordability-and-access-to-healthcare/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=increasing-penetration-of-health-insurance-an-important-way-to-improve-affordability-and-access-to-healthcare</link>
		<comments>http://www.tapanray.in/increasing-penetration-of-health-insurance-an-important-way-to-improve-affordability-and-access-to-healthcare/#comments</comments>
		<pubDate>Mon, 27 Jul 2009 01:00:08 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[important]]></category>
		<category><![CDATA[improve]]></category>
		<category><![CDATA[Increasing]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[penetration]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[way]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=824</guid>
		<description><![CDATA[While India is making rapid strides in its economic growth, the country is increasingly facing constraints in providing healthcare benefits to a vast majority of its population. This is mainly because of the following reasons:1. Inadequate healthcare infrastructure and delivery &#8230; <a href="http://www.tapanray.in/increasing-penetration-of-health-insurance-an-important-way-to-improve-affordability-and-access-to-healthcare/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/increasing-penetration-of-health-insurance-an-important-way-to-improve-affordability-and-access-to-healthcare/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Global API manufacturers are poised to penetrate the Indian market in a bigger way – will the API &#8216;marketing warfare&#8217; be even more intense, in future?</title>
		<link>http://www.tapanray.in/global-api-manufacturers-are-poised-to-penetrate-the-indian-market-in-a-bigger-way-will-the-api-marketing-warfare-be-even-more-intense-in-future/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=global-api-manufacturers-are-poised-to-penetrate-the-indian-market-in-a-bigger-way-will-the-api-marketing-warfare-be-even-more-intense-in-future</link>
		<comments>http://www.tapanray.in/global-api-manufacturers-are-poised-to-penetrate-the-indian-market-in-a-bigger-way-will-the-api-marketing-warfare-be-even-more-intense-in-future/#comments</comments>
		<pubDate>Mon, 25 May 2009 01:00:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[API]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[bigger]]></category>
		<category><![CDATA[bulk]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[future]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[intense]]></category>
		<category><![CDATA[manufacturers]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[more]]></category>
		<category><![CDATA[penetrate]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[poised]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[warfare]]></category>
		<category><![CDATA[way]]></category>
		<category><![CDATA[Will]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=878</guid>
		<description><![CDATA[India currently plays a relatively dominant role in the Global Active Pharmaceutical Ingredient (API) Market with China being ahead of India. While this is the current scenario, many experts in this field contemplates that important players from the regulated markets &#8230; <a href="http://www.tapanray.in/global-api-manufacturers-are-poised-to-penetrate-the-indian-market-in-a-bigger-way-will-the-api-marketing-warfare-be-even-more-intense-in-future/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/global-api-manufacturers-are-poised-to-penetrate-the-indian-market-in-a-bigger-way-will-the-api-marketing-warfare-be-even-more-intense-in-future/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>From ‘Blockbuster Drugs’ to &#8216;Personalized Medicines’ – will it revolutionize the way the patients will be treated tomorrow?</title>
		<link>http://www.tapanray.in/from-blockbuster-drugs-to-personalized-medicines-will-it-revolutionize-the-way-the-patients-will-be-treated-tomorrow/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=from-blockbuster-drugs-to-personalized-medicines-will-it-revolutionize-the-way-the-patients-will-be-treated-tomorrow</link>
		<comments>http://www.tapanray.in/from-blockbuster-drugs-to-personalized-medicines-will-it-revolutionize-the-way-the-patients-will-be-treated-tomorrow/#comments</comments>
		<pubDate>Wed, 15 Apr 2009 18:00:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[From Blockbuster]]></category>
		<category><![CDATA[it]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[personalized]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[revolutionize]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[Tomorrow]]></category>
		<category><![CDATA[treated]]></category>
		<category><![CDATA[way]]></category>
		<category><![CDATA[Will]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=915</guid>
		<description><![CDATA[Financial Times quoted Jeff Kendler, the CEO of Pfizersaying, “the era of dependence on a single or a couple of blockbuster drugs should be over. Lipitor sells U.S$ 12 billion a year. You can’t build a company predicted on the &#8230; <a href="http://www.tapanray.in/from-blockbuster-drugs-to-personalized-medicines-will-it-revolutionize-the-way-the-patients-will-be-treated-tomorrow/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/from-blockbuster-drugs-to-personalized-medicines-will-it-revolutionize-the-way-the-patients-will-be-treated-tomorrow/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Improving ‘Access to Modern Medicines’ in India –Public Private Partnership (PPP) is the way forward.</title>
		<link>http://www.tapanray.in/improving-access-to-modern-medicines-in-india-public-private-partnership-ppp-is-the-way-forward/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=improving-access-to-modern-medicines-in-india-public-private-partnership-ppp-is-the-way-forward</link>
		<comments>http://www.tapanray.in/improving-access-to-modern-medicines-in-india-public-private-partnership-ppp-is-the-way-forward/#comments</comments>
		<pubDate>Wed, 01 Apr 2009 16:00:22 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[forward]]></category>
		<category><![CDATA[Improving]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Modern]]></category>
		<category><![CDATA[Partnership]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPP]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[private]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[way]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=926</guid>
		<description><![CDATA[Despite various measures being taken by the Government of India (GoI) from time to time, around 65% of Indian population are not having access to modern medicines. It appears, GoI is of the view that the reason for poor &#8216;access &#8230; <a href="http://www.tapanray.in/improving-access-to-modern-medicines-in-india-public-private-partnership-ppp-is-the-way-forward/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/improving-access-to-modern-medicines-in-india-public-private-partnership-ppp-is-the-way-forward/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
